UHRF1 and astrocytoma (excluding glioblastoma): Similarly, our recent study suggests that activation of highly expressed membrane integrin CD47 in astrocytoma activates NFκB-mediated signaling and UHRF1 expression, which in turn represses p16, thereby strengthening the tumor promoter role of UHRF1 [48].